GILD was lagging IBB (risk appetite was high and people was taking profit out of GILD and put it into next blockbuster).
It has decoupled from IBB and showing some sign of rising long interest on it. Also, it hit the long term resisting trendline and held up. Best strategy at the moment is long GILD and short IBB (reduce your risk and increase your gain in case biotech burst).
BTW: BIS is double short IBB.
It has decoupled from IBB and showing some sign of rising long interest on it. Also, it hit the long term resisting trendline and held up. Best strategy at the moment is long GILD and short IBB (reduce your risk and increase your gain in case biotech burst).
BTW: BIS is double short IBB.
